Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader in pharmaceutical formulation science, today announced a ground-breaking ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Bucheerei’s appointment comes at a pivotal time as Ithmaar Bank advances its comprehensive restructuring and transformation programme aimed at strengthening its business model ...

MANAMA, BAHRAIN – Ithmaar Bank B.S.C. (closed), a Bahrain-based Islamic retail bank, announced the appointment of Mohamed ...

Biomind Labs Inc ( ($TSE:BMND) ) has issued an update. Biomind Labs Inc. has announced a significant strategic advancement in the development of ...

MidSolid, formerly known as Custom Soap Colorado and Rocky Mountain Body Works & Co., has announced significant enhancements to its manufacturing capabilities for solid shampoo and conditioner bars, ...

An organoid standards working group has been established, bringing together experts from around the world, with Chinese scholars leading the effort to gather international expertise to develop a ...

Viking Therapeutics advances oral and injectable VK2735 for obesity with strong cash, pipeline depth, and key 2026 catalysts.

Quotient Sciences and Intrepid Labs have announced a multi-year strategic partnership to advance the use of artificial intelligence (AI) in early drug development.

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

Active Biotech AB ( ($SE:ACTI) ) has provided an update. Active Biotech announced that its patent for a pharmaceutical formulation of tasquinimod ...

Natco rode Revlimid to multi-year highs, but that one-time opportunity is tapering fast. With earnings set to plunge and ...